Livelihood security and adherence to antiretroviral therapy in low and middle income settings: A systematic review

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Rachlis, Beth S ^a   Mills, Edward J ^b   Cole, Donald C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EDUCATIONAL STATUS; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH DISPARITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; PATIENT ATTITUDE; PATIENT COMPLIANCE; REVIEW; SOCIAL CAPITAL; SOCIAL SECURITY; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; TREATMENT REFUSAL; CROSS-SECTIONAL STUDY; ECONOMICS; INCOME; POVERTY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT;

ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; GUIDELINE ADHERENCE; HIV INFECTIONS; HUMANS; INCOME; POVERTY;

EID: 79955934223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018948     Document Type: Review

References (85)

1. Drimie S, Mullins D, (2006) Mainstreaming HIV and AIDS into livelihood and food security programs: The experience of CARE Malawi. In: Gillespie, S, editors. pp. 283-303 AIDS, poverty, and hunger: Challenges and responses. Highlights of the International Conference on HIV/AIDS and Food and Nutrition Security, Durban South Africa, April 14-16, 2005. Washington, DC: International Food Policy Research Network.
2. Elasha BO, Elhassan NG, Ahmed H, Zakeildin S, (2005) Sustainable livelihood approach for assessing community resilience to climate change: case studies from Sudan. Assessments of Impacts and Adaptation to Climate Change working paper No 17. August 2005. Available: http://www.aiaccproject.org/working_papers/Working%20Papers/AIACC_WP_No 017.pdf. Accessed on 3 February, 2010.
3. Carney B, (1998) Sustainable Rural Livelihoods-what contributions can we make? Paper presented at the Department of International Development's Natural Resources Advisers' Conference London.
4. De Waal A, Whiteside A, (2003) New variant famine: AIDS and food crisis in Southern Africa. Lancet 362: 1234-1237.
5. Masanjala W, (2007) The poverty-HIV/AIDS nexus in Africa: a livelihood approach. Soc Sci Med 64: 1032-1041.
6. Seeley J, (2002) Thinking with the livelihood framework in the context of the HIV/AIDS epidemic. Research paper, Livelihoods Connect, Institute of Development Studies, University of Sussex.
7. Ellis F, Kutengule M, Nyasulu A, (2003) Livelihoods and rural poverty education in Malawi. World Dev 31: 1495-1510.
8. Hogg RS, O'Shaughnessy MV, Gataric N, Yip B, Craib K, et al. (1997) Decline in deaths from AIDS due to new antiretrovirals. Lancet 349: 1294.
9. Mannheimer SB, Matts J, Telzak E, Chesney M, Child C, et al. (2005) Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care, 1: 10-22.
10. Joint United Nations Programme on HIV/AIDS (2009) Report on the Global AIDS Pandemic. Available: http://www.unaids.org/en/KnowledgeCentre/HIVData/Global-Report/2009/. Accessed on 3 Jan 2010.
11. Gavian S, Galaty D, Kombe, K, (2006) Multisectoral HIV/AIDS approaches in Africa: How are they evolving? In: Gillespie, S, editors. pp. 221-243 AIDS, poverty, and hunger Challenges and responses. Highlights of the International Conference on HIV/AIDS and Food and Nutrition Security, Durban South Africa, April 14-16, 2005. Washington, DC: International Food Policy Research Network.
12. Bangsberg DR, Perry S, Charlesbois ED, Clark RA, Robertson M, et al. (2001) Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 15: 1181-1183.
13. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, et al. (2003) Is there a baseline CD4 count that precludes a survival response to modern antiretroviral therapy? AIDS 17: 711-720.
14. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, et al. (2006) Adherence to antiretroviral therapy in sub-Saharan Africa and North America. A meta-analysis. JAMA 296: 679-690.
15. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al. (2006) Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 3: e438.
16. Altice FL, Mostashari F, Friedland GH, (2001) Trust and the acceptance of and adherence to antiretroviral therapy. JAIDS 1: 47-58.
17. Loevinsohn M, Gillespie SR, (2003) HIV/AIDS, rural livelihoods and food security: understanding and responding. RENEWAL Working paper No 2. Available: www.isnar.org/renewal. Accessed on 10 Jan 2010.
18. Ivers L, Kendrick D, Doucette K, (2005) Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analyses of the published literature. HIV/AIDS Clin Infect Dis 41: 217-24.
19. UK Department of Development (2004) Sustainable livelihoods guidance sheets. London, Department for International Development. Available: http://www.ennonline.net/pool/files/ife/section2.pdf. Accessed on 20 July 2009.
20. Stroup DF, Berlin JA, Morton CS, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 282: 2008-2012.
21. World Bank. Country Classification Table. Available: http://go.worldbank.org/K2CKM78CC0. Accessed on 10 Jan 2010.
22. Katrak P, Bialocerkowski AE, Massy-Westropp N, Kumar VSS, Grimmer KA, (2004) A systematic review of the content of critical appraisal tools. BMC Med Res Method 4: 22.
23. Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, et al. STROBE Initiative (2008) The strengthening of reporting of observational studies in epidemiology (STROBE) statement guidelines for reporting observational studies. J Clin Epidemiol 61: 344-9.
24. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, et al. (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 4: e297.
25. Public Health Resource Unit. Critical appraisal skills programme: making sense of evidence. 12 Questions to help you make sense of a cohort study. Available: http://www.phru.nhs.uk/Doc_Links/cohort%2012%20questions.pdf. Accessed on 31 January 2010.
26. Aboubacrine SA, Niamba P, Bioleau C, Zunzunegui MV, Machouf N, et al. (2007) Inadequate adherence to antiretroviral treatment and prevention in hospital and community sites in Burkina Faso and Mali: a study by the ATARAO group. Int J STD AIDS 18: 741-7.
27. Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, et al. (2009) Financial barriers to HIV treatment in Yaoundé, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ 87: 279-87.
28. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, et al. (2005) Adherence to HIV antiretroviral therapy in HIV+Ugandan patients purchasing therapy. Int J STD AIDS 16: 38-41.
29. Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, et al. (2008) Predictors of adherence to antiretroviral therapy in rural Zambia. JAIDS 47: 615-622.
30. Iliyasu Z, Kabir M, Abubakar IS, Babashani M, Zubair ZA, (2005) Compliance to antiretroviral therapy among AIDS patients in Amino Kano Teaching Hospital, Kano, Nigeria. Niger J Med 14: 290-4.
31. Malangu NG, (2008) Self-reported adverse effects as barriers to adherence to antiretroviral therapy in HIV-infected patients in Pretoria. SA Family Practice 50: 49.
32. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, et al. (2004) Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Human Retro 20: 1053-1056.
33. Nemes MI, Carvalho HB, Souza MF, (2004) Antiretroviral therapy adherence in Brazil. AIDS 18 (Suppl 3) pp. S15-20.
34. Pinheiro CAT, de-Carvalho-Leite JC, Drachler ML, Silveria VL, (2002) Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Br J Med Biological Research 35: 1173-1181.
35. Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F, et al. (2007) Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis 45: 1492-8.
36. Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, et al. (2008) Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Ind J Med Res 127: 28-36.
37. Silva MCF, Ximenes RAA, Mirando Filho DB, Arraes LWMS, Mendes M, et al. (2009) Risk factors for non-adherence to antiretroviral therapy. Rev Inst Med Trop S. Paulo 51: 135-139.
38. Stout BD, Leon MP, Niccolai LM, (2004) Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica. AIDS Patient Care STDS 18: 297-304.
39. Uzochukwu BSC, Onwujekwe OE, ONoka AC, Okoli C, Uguru NP, et al. (2009) Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health Policy Plan 24: 189-96.
40. Wang X, Wu Z, (2007) Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China. AIDS 21 (Suppl 8) pp. S149-S155.
41. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, et al. (2003) Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. JAIDS 34: 281-288.
42. Williams M, Clarke T, Williams P, Barton EN, (2007) The mean levels of adherence and factors contributing to non-adherence in patients on highly active antiretroviral therapy. West Indian Med J 56: 270.
43. Bonolo P, Cesar CC, Acurcio FA, Ceccato MGB, de Padua CM, et al. (2005) Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil. AIDS 19: S5-13.
44. Erah PO, Arute JE, (2008) Adherence of HIV/AIDS patients to antiretroviral therapy in a tertiary health facility in Benin City. Afr J Pharmacy Pharmacology 2: 145-152.
45. Orrell C, Bangsberg DR, Badri M, Wood R, (2003) Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 17: 1369-75.
46. Dahab M, Charalambous S, Hamilton R, Fielding K, Tsimele J, et al. (2006) A quantitative study of barriers & facilitators to adherence in an ART programme in South Africa. AIDS 2006-XVI International AIDS Conference: Abstract no. TUPE0151.
47. Shah B, Walshe L, Saple DG, Mehta S, Kharkar JP, et al. (2006) Adherence to antiretroviral therapy among Indian HIV-infected persons seeking care in the private sector in Mumbai, India. AIDS 2006-XVI International AIDS Conference: Abstract no. THPE0194.
48. Warley E, Shield D, Salas M, Vienie I, Moneti S, et al. (2006) Adherence to antiretroviral therapy in a population of the low-income suburbs of Buenos Aires, Argentina. AIDS 2006-XVI International AIDS Conference: Abstract no. CDB0805.
49. Abah IO, Falang K, Finangwi A, Iyaji P, Wakdet L, et al. (2006) Adherence to antiretroviral therapy in HIV-infected adults in Jos, Nigeria. AIDS 2006-XVI International AIDS Conference: Abstract no. TUPE0105.
50. Darder M, Michaels D, Boulle A, Ncobo N, MacLean E, et al. (2004) Determinants of short and long-term adherence to antiretroviral treatment in resource-poor settings. CD Only: The XV International AIDS Conference 2004: Abstract no. B11852.
51. Sidle J, Kimaiyo S, Monahan P, Nyandiko W, Wools-Kaloustian K, et al. (2007) Patterns of antiretroviral adherence among Kenyan patients and factors related to non-adherence during the first year of treatment. Poster exhibition: 4th IAS Conference no HIV Pathogenesis, Treatment, and Prevention 2007: Abstract no. WEPEB099.
52. Shelton JD, (2007) Ten myths and one truth about generalised HIV epidemics. Lancet 370: 1809-11.
53. Talam NC, Gatongi P, Rotich J, Kimaiyo S, (2008) Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and referral hospital, Eldoret, Kenya. East Afr J Public Health 5: 74-78.
54. Nwauche CA, Erhabor O, Ejele OA, Akani C, (2006) Adherence to antiretroviral therapy among HIV-infected subjects in resource-limited setting in the Niger Delta of Nigeria. Afr J Health Sci 13: 13-17.
55. Bandura A, (1997) Self-efficacy: the exercise of control. W.H. Freeman & Company. New York, NY, USA.
56. Daniel OJ, (2004) Adherence pattern to ARV drugs among patients on self-purchased drugs and those on free medications in Sagamu, Nigeria. XV International AIDS Conference, Thailand. Abstract WePeB5768.
57. Laniece I, Ciss M, Desclaux A, Diop K, Mbodje F, et al. (2003) Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS 17 (Suppl 3) pp. S103-108.
58. Kumaraswamy N, Safren SA, Raminani SR, Pickard R, James R, et al. (2005) Barriers and facilitators to antiretroviral medication adherence among patients living with HIV in Chennai, India; A qualitative study AIDS Patient Care STDS 19: 526-37.
59. Moss AR, Hahn JA, Perry S, Charlesbois ED, Guzman D, et al. (2004) Adherence to highly active antiretroviral therapy in the homeless population of San Francisco: A prospective study. Clin Infect Dis 39: 1190-1198.
60. Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, et al. (2010) Transportation costs impeded sustained adherence and access to HAART in a clinic population in Southwestern Uganda: a qualitative study. AIDS Behav 14: 778-84.
61. Anema A, Vogenthaler N, Frongillo EA, Kadiyala S, Weiser SD, (2009) Food insecurity and HIV/AIDS: current knowledge, gaps, and research priorities. Curr HIV/AIDS Res 6: 224-231.
62. Cauldbeck MB, O'Connor C, O'Connor MB, Saunders JA, Rao B, et al. (2009) Adherence to antiretroviral therapy among HIV patients in Bangalore India. AIDS Res Ther 6: 7.
63. Au JT, Kayitenkore K, Shutes E, Karita E, Peters PJ, et al. (2006) Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda. AIDS 20: 2116-18.
64. Weiser SD, Frongillo EA, Ragland K, Hogg RS, Riley ED, et al. (2008) Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. J Gen Intern Med 24: 14-20.
65. Weiser SD, Fernandes K, Brandson EK, Lima VD, Anema A, et al. (2009) The association between food insecurity and mortality among HIV-infected individuals on HAART. JAIDS 52: 342-9.
66. Ickovics JR, Meade CS, (2002) Adherence to HAART among patients with HIV: breakthroughs and barriers AIDS Care 14: 309-318.
67. Sanjobo N, Frich JC, Freitheim A, (2008) Barriers and facilitators to patients' adherence to antiretroviral adherence to antiretroviral treatment in Zambia. SAHARA J 5: 136-43.
68. Unge C, Johansson A, Zachariah R, Some D, Van Engelgem I, et al. (2006) Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care 20: 146-49.
69. Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, et al. (2003) Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities AIDS Behav 7: 61-72.
70. Ware NC, Idoko J, Kaaya S, Biararo IA, Wyatt MA, et al. (2009) Explaining adherence successes in sub-Saharan Africa: an ethnographic study. PLoS Med 6: e1000011.
71. Watt MH, Maman S, Earp JA, Eng E, Setel PW, et al. (2009) "It's all the time in my mind": Facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med 68: 1793-1800.
72. Diabete S, Alary M, Koffi CK, (2007) Determinants of adherence to highly active antiretroviral therapy among HIV-1 infected patients in Cote D'Ivoire. AIDS 21: 1799-1803.
73. Nam SL, Fielding K, Avalos A, Dickenson D, Gaoathe T, et al. (2008) The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med 67: 301-10.
74. Birbeck GL, Chomba E, Kvalsund M, Bradbury R, Mang'ombe C, et al. (2009) Antiretroviral adherence in Rural Zambia; the first year of treatment availability. Am J Trop Med 80: 669-74.
75. World Health Organization (2008) Priority interventions: HIV/AIDS prevention, treatment and care in the health sector. Geneva WHO.
76. Kalichman SC, Ramachandran B, Catz S, (1999) Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med 14: 267-73.
77. Norman A, Chopra M, Kadiyala S, (2007) Factors related to HIV disclosure in 2 South African communities. Am J Public Health 97: 1775-81.
78. Ncama BP, McInerney PA, Bhengu BR, Corless IB, Wantland DJ, et al. (2008) Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa. Int J Nurs Stud 45: 1757-63.
79. Berg KM, Arnsten JH, (2006) Practical and conceptual challenges in measuring antiretroviral adherence. JAIDS 43: S79-S87.
80. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, et al. (2001) A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 137: 968-977.
81. Nachega JB, Mills EJ, Schechter M, (2010) Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS 5: 70-77.
82. Wagner G, Miller LG, (2004) Is the influence of social desirability on patients' self-reported adherence overrated? JAIDS 35: 203-204.
83. Castro A, (2005) Adherence to antiretroviral therapy: merging the clinical and social course of AIDS. PLoS Med 2: e338.
84. Naik E, Casanas B, Pazare A, Wabale G, Sinnott J, et al. (2009) Cost of treatment: the single biggest obstacle to HIV/AIDS treatment adherence in lower-middle class patients in Mumbai, India. Ind J Sex Transmit Dis 40: 23-27.
85. Mondloch MV, Cole DC, Frank JW, (2001) Does how you do depend on how you think you'll do? A systematic review of the evidence for a relation between patients' recovery expectations and health outcomes. CMAJ 165: 174-79.